MoneyWorks4Me

Onesource Specialty Pharma informs about disclosures

23 Dec 2025 Evaluate
Onesource Specialty Pharma has informed that the Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 23, 2025 for Tenshi Pharmaceuticals.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..